MAK16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.615200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.648400E-01
Normal-vs-Stage2
5.950600E-01
Normal-vs-Stage3
2.487400E-01
Normal-vs-Stage4
3.347000E-01
Stage1-vs-Stage2
9.722000E-01
Stage1-vs-Stage3
4.154400E-01
Stage1-vs-Stage4
9.699800E-02
Stage2-vs-Stage3
4.658000E-01
Stage2-vs-Stage4
1.291800E-01
Stage3-vs-Stage4
3.348000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.359200E-01
Normal-vs-AfricanAmerican
5.868200E-01
Normal-vs-Asian
1.637040E-01
Caucasian-vs-AfricanAmerican
6.231600E-02
Caucasian-vs-Asian
2.601000E-01
AfricanAmerican-vs-Asian
2.598400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.817600E-01
Normal-vs-Female
6.844400E-01
Male-vs-Female
2.221400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.264600E-01
Normal-vs-Age(41-60Yrs)
8.829800E-01
Normal-vs-Age(61-80Yrs)
5.096600E-01
Normal-vs-Age(81-100Yrs)
6.424300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.942200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.944400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.270200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.136000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.234110E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.755800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.886230E-01
Normal-vs-Daily Drinker
1.521390E-01
Normal-vs-Weekly Drinker
9.443400E-01
Normal-vs-Occasional Drinker
5.444400E-01
Normal-vs-Social Drinker
9.327200E-01
Non Drinker-vs-Daily Drinker
5.020600E-01
Non Drinker-vs-Weekly Drinker
8.385500E-02
Non Drinker-vs-Occasional Drinker
2.318600E-01
Non Drinker-vs-Social Drinker
6.030200E-02
Daily Drinker-vs-Weekly Drinker
2.540200E-02
Daily Drinker-vs-Occasional Drinker
1.120570E-01
Daily Drinker-vs-Social Drinker
3.781700E-02
Weekly Drinker-vs-Occasional Drinker
3.207600E-01
Weekly Drinker-vs-Social Drinker
8.012200E-01
Occasional Drinker-vs-Social Drinker
4.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.195800E-01
Normal-vs-Grade 2
7.933400E-01
Normal-vs-Grade 3
8.129200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.054200E-01
Grade 1-vs-Grade 3
5.122200E-01
Grade 1-vs-Grade 4
7.195800E-01
Grade 2-vs-Grade 3
7.414200E-01
Grade 2-vs-Grade 4
7.933400E-01
Grade 3-vs-Grade 4
8.129200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.858600E-01
Normal-vs-NonDiabetic
4.521800E-01
Diabetic-vs-NonDiabetic
8.010200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.643800E-01
Normal-vs-NoPancreatitis
5.129800E-01
Pancreatitis-vs-NoPancreatitis
4.298600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.505400E-01
Normal-vs-N1
5.985400E-01
N0-vs-N1
6.350000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.774000E-01
Normal-vs-TP53-NonMutant
6.096600E-01
TP53-Mutant-vs-TP53-NonMutant
7.152200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
